Defects in the BER pathway can lead to an accumulation of DNA damage, increasing the risk of mutations and cancer. Genetic polymorphisms in BER-related genes have been linked to a heightened susceptibility to various cancers and other diseases. Additionally, BER-deficient cells are more sensitive to certain chemotherapeutic agents, which can be exploited in cancer treatment strategies.
